New member | PhosphoTech
17 January 2022PhosphoTech Laboratories is an international player specialising in the production of high added value marine ingredients. The company is based... View Article
New member | Stimul’in
12 January 2022The mission of Stimul’in is to enhance the daily life of people with neurocognitive troubles, their families and their health... View Article
InFlectis BioScience receives approval from the French regulatory authority to conduct a phase 2 clinical trial for IFB-088 (Icerguastat) for the treatment of Amyotrophic Lateral Sclerosis
11 January 2022InFlectis BioScience, a clinical-stage company developing innovative therapeutics for neuromuscular diseases by harnessing the Integrated Stress Response (ISR), receives approval from the... View Article